Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Expert Opinion on Drug Discovery|July 1, 2021
Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases - where are we presently?Christian GegeExpert Opinion on Therapeutic Patents|February 20, 2016
Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742Christian GegeExpert Opinion on Therapeutic Patents|November 18, 2016
RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345Christian GegeExpert Opinion on Therapeutic Patents|July 10, 2015
Retinoid-related orphan receptor γ t modulators: comparison of Glenmark's me-too patent application (WO2015008234) with the originator application from Merck Sharp and Dohme (WO2012106995)Christian GegeBioorganic & Medicinal Chemistry Letters|April 20, 2024
Replacement of sulfonamide by sulfoximine within a helicase-primase inhibitor with restricted flexibilityChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|July 27, 2026
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverageChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|August 15, 2022
Helicase-primase inhibitors from Medshine Discovery Inc. (WO2018/127207 and WO2020/007355) for the treatment of herpes simplex virus infections - structure proposal for Phaeno Therapeutics drug candidate HN0037Christian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|August 19, 2025
Evaluation of the patent portfolio for helicase-primase inhibitor ABI-5366 of Assembly biosciences incChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|September 12, 2024
Helicase-primase inhibitors for the treatment of herpes simplex virus infections - patent evaluation of WO2023/225162 from Gilead Sciences IncChristian Gege, Gerald KleymannCarbohydrate Research|June 14, 2002
Synthesis of dimeric lactose and dimeric (sialyl) Lewis(X) glycolipidsChristian Gege, Richard R SchmidtPageof 6